Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers.

Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers. iScience. 2026 Jun 19; 29(6):116184.

View in: PubMed